The DELVES Feasibility study

  • Research type

    Research Study

  • Full title

    Developing and Evaluating the Digitally Enhanced Liberation from VEntilation (DELVE) System - A Study of Feasibility and User Acceptance

  • IRAS ID

    249143

  • Contact name

    Charlotte Small

  • Contact email

    drcharlottesmall@gmail.com

  • Sponsor organisation

    University Hospitals Birmingham NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 9 months, 1 days

  • Research summary

    Some patients recovering from severe or critical illness on the Intensive Care Unit are treated with
    mechanical ventilation. This supports the patients’ breathing, reducing effort required to breathe in
    addition to providing extra oxygen if needed. Patients who have been very unwell, or need
    mechanical ventilation for more than a few days, may become dependant on the support provided
    and need training to breathe by themselves. This process is termed “weaning.” Patients usually
    undergo a tracheostomy, a hole through the neck into the trachea (windpipe), which is more
    comfortable than having the tube through the mouth. The sedation they need is then reduced and
    they are woken up, as the support provided by the ventilator is slowly reduced. For some patients,
    this process can take days or weeks, with complications and set backs. The process is often
    uncomfortable, distressing and requires the resources of the intensive care unit, so it is important
    to try to understand how we can make the weaning process as effective and quick as possible.
    Current evidence suggests that we don’t yet understand many of the factors that influence the
    success of weaning, but that a consistent approach is likely to be beneficial. Current systems used
    to prescribe and monitor progress use different methods of documentation, including paper charts
    and electronic records, which can be difficult to interpret. A new device has been developed, the
    “Digitally Enhanced Liberation from VEntilation” or “DELVE” system which has been designed to
    improve the clinical team’s ability to prescribe the weaning plan, and interpret the patients’
    progress. The DELVE system will also collect data which will help us to better understand some of
    the factors that influence rate of weaning. This trial is a feasibility study of this novel device in the
    ICU setting, to include evaluation of user acceptance, prior to a future definitive trial of
    effectiveness.

  • REC name

    Wales REC 6

  • REC reference

    19/WA/0092

  • Date of REC Opinion

    3 May 2019

  • REC opinion

    Further Information Favourable Opinion